Parkside Financial Bank & Trust Increases Stock Holdings in UnitedHealth Group Incorporated $UNH

Parkside Financial Bank & Trust raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 15.7% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,072 shares of the healthcare conglomerate’s stock after buying an additional 960 shares during the quarter. Parkside Financial Bank & Trust’s holdings in UnitedHealth Group were worth $2,206,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Magellan Asset Management Ltd raised its position in shares of UnitedHealth Group by 47.5% in the 2nd quarter. Magellan Asset Management Ltd now owns 822,867 shares of the healthcare conglomerate’s stock worth $256,710,000 after buying an additional 264,955 shares during the period. Los Angeles Capital Management LLC grew its holdings in shares of UnitedHealth Group by 105.6% during the 2nd quarter. Los Angeles Capital Management LLC now owns 31,813 shares of the healthcare conglomerate’s stock worth $9,925,000 after purchasing an additional 16,336 shares during the period. ZEGA Investments LLC raised its holdings in UnitedHealth Group by 5.8% in the second quarter. ZEGA Investments LLC now owns 10,654 shares of the healthcare conglomerate’s stock valued at $3,324,000 after buying an additional 584 shares during the period. Prospera Financial Services Inc increased its position in shares of UnitedHealth Group by 60.9% in the second quarter. Prospera Financial Services Inc now owns 42,066 shares of the healthcare conglomerate’s stock worth $13,129,000 after acquiring an additional 15,920 shares in the last quarter. Finally, True Wealth Design LLC boosted its position in UnitedHealth Group by 94.7% during the 2nd quarter. True Wealth Design LLC now owns 364 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 177 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $324.29 on Friday. The company has a market capitalization of $293.75 billion, a price-to-earnings ratio of 16.93, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The business has a 50 day simple moving average of $345.84 and a 200-day simple moving average of $323.37. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the previous year, the firm earned $7.15 earnings per share. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. Sanford C. Bernstein upped their target price on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. TD Cowen lifted their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research note on Thursday, October 30th. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Finally, KeyCorp raised their price objective on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.